Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Xavier Raga"'
3
Akademický článek
Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
Autor: Angel Vila-Corcoles, Olga Ochoa-Gondar, Cinta de Diego, Eva Satue, María Aragón, Angel Vila-Rovira, Frederic Gomez-Bertomeu, Ramon Magarolas, Enric Figuerola-Massana, Xavier Raga, Mar O. Perez, Frederic Ballester
Publikováno v: BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness of PCV13 vaccination in preventing hospitalisation from pneumonia among middle-aged an
Externí odkaz: https://doaj.org/article/6d966d5d3f224088850dd44044f1cccd
Zobrazit plný text záznamu
4
Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015–2016
Autor: Angel Vila-Corcoles, Immaculada Hospital, Olga Ochoa-Gondar, Eva Satue, Cinta de Diego, Angel Vila-Rovira, Frederic Gómez-Bertomeu, Xavier Raga, María Aragón
Publikováno v: Vaccine. 38:1170-1180
Clinical benefits using the 23-valent pneumococcal polysaccharide vaccine (PPsV23) or the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness for both PPsV23 and PCV13 in preven
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d35d1ad4a95dc6e2423f845741de15d
https://doi.org/10.1016/j.vaccine.2019.11.012
Zobrazit plný text záznamu
5
The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage
Autor: Pilar Ciruela, Conchita Izquierdo, Sonia Broner, Carmen Muñoz-Almagro, Sergi Hernández, Carmen Ardanuy, Roman Pallarés, Angela Domínguez, Mireia Jané, Cristina Esteva, Mariona Fernández de Sevilla, Desiree Henares, Immaculada Grau, Francesc Marco, Jaume Llaberia, Araceli González-Cuevas, Alvaro Díaz, Maria Teresa Martin, Montserrat Sierra, Margarida Curriu, Carme Gallés, Pilar Hernández, Paula Gassiot, Matilde Martínez-Zurita, Carmina Martí, Montserrat Morta, Goretti Sauca, Asunción Gassós, Esther Sanfeliu, Frederic Ballester, Isabel Pujol, Montserrat Olsina, Xavier Raga, Frederic Gómez-Bertomeu, Mar Olga Pérez-Moreno, Anna Vilamala, Marian Navarro, Mercè Ribelles, Eduardo Padilla, Nuria Prim, Dionisia Fontanals, Miguel Angel Benítez, Eulalia Jou, Carmina Sanjosé, Montserrat Giménez, Maria Dolores Quesada, Jose Carlos de la Fuente, Ana Calderon, Percy Juan Ayala, Laia Vega, Josefa Pérez-Jové, Conchita Balado, Ines Valle
Publikováno v: Vaccine. 36:7744-7752
BACKGROUND We studied the impact of 13-valent pneumococcal conjugate vaccine (PCV13) on the incidence of invasive pneumococcal disease (IPD) and serotype distribution in a region with intermediate levels of vaccination (around 64% in children aged
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba5575ae9c90e6bcdb1c796853caf0c
https://doi.org/10.1016/j.vaccine.2018.05.026
Zobrazit plný text záznamu
6
Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007–2013: Incidence, serotype distribution and vaccine's effectiveness
Autor: C. de Diego, Enric Figuerola-Massana, C A Aguirre, Olga Ochoa-Gondar, Frederic Gomez, Xavier Raga, Eva Satué, Angel Vila-Corcoles
Publikováno v: International Journal of Pediatric Otorhinolaryngology. 79:2104-2108
Objective This study investigated incidence and serotype distribution of Streptococcus pneumoniae causing acute otitis media (AOM) in Catalonian children, evaluating vaccination effectiveness in the current era of extended valency pneumococcal conjug
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9832f117e70c833b370bee3e97c7d14b
https://doi.org/10.1016/j.ijporl.2015.09.022
Zobrazit plný text záznamu
7
[Epidemiology of invasive pneumococcal disease in Tarragona, Spain, 2012-2015: incidence, lethality and serotype-coverage for distinct antipneumococcal vaccine formulations]
Autor: Ángel, Vila Córcoles, Cristina, Dacosta Moreira, Cinta, de Diego Cabanes, Olga, Ochoa Gondar, Marta, Raga Gutiérrez, Frederic, Gómez Bertomeu, Xavier, Raga Luria, Enric, Figuerola Massana
Publikováno v: Revista espanola de salud publica. 92
Nowadays, after licensure of the second generation new pneumococcal conjugate vaccines (PCV10/PCV13). The epidemiology of the pneumococcal disease must be re-evaluated. The present study described incidence, lethality and serotype distribution of inv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::63f219d063e5d861c5223ec34c9067b2
https://pubmed.ncbi.nlm.nih.gov/30280720
Zobrazit plný text záznamu
8
Influence of chronic illnesses and underlying risk conditions on the incidence of pneumococcal pneumonia in older adults
Autor: Luis Barnes, Olga Ochoa-Gondar, Leonardo Esteban, Carlos Aguirre-Chavarria, Xavier Raga, Teresa Rodriguez-Blanco, Ramon Magarolas, Cinta de Diego, Angel Vila-Corcoles, Frederic Gomez
Publikováno v: Infection. 43:699-706
To investigate hospitalizations from pneumococcal pneumonia in older adults with specific underlying chronic conditions, evaluating the influence of these conditions in developing pneumonia.Population-based cohort study involving 27,204 individuals
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a36c91c0b1829a4e0f28f199414578
https://doi.org/10.1007/s15010-015-0801-y
Zobrazit plný text záznamu
10
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study
Autor: Xavier Raga-Luria, Olga Ochoa-Gondar, Angel Vila-Corcoles, Enric Figuerola-Massana, Teresa Rodriguez-Blanco, Imma Hospital-Guardiola, Frederic Gomez-Bertomeu
Publikováno v: Clinical Infectious Diseases. 58:909-917
Background. The benefits of using the 23-valent pneumococcal polysaccharide vaccine (PPV23) are controversial. This study assessed clinical effectiveness of PPV23 in preventing community-acquired pneumonia (CAP) among the general population aged ≥6
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e13f095d6c5d7915c7b11cfdd0112af
https://doi.org/10.1093/cid/ciu002
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje